Brazil Threatens To Break Merck’s Efavirenz Patent

Law360, New York (April 26, 2007, 12:00 AM EDT) -- Brazil on Wednesday reportedly threatened to break Merck & Co. Inc.’s patent on HIV/AIDS drug Efavirenz, warning it will tap into India’s generic drug industry if the pharmaceutical giant will not offer the country a lower price for the much-needed medicine.

Health Minister Jose Gomes Temporao on Wednesday identified Efavirenz, an antiretroviral drug used to treat HIV and AIDS, as a "public interest" medicine and gave Merck one week to negotiate a discounted price with the Brazilian government, the Associated Press reported.

If negotiations fail, Brazil...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.